...that the Band-Aid Bandage was invented by a Johnson & Johnson employee whose wife had cut herself? Earl Dickson's wife was rather accident prone, so he set out to develop a bandage that she could apply without help. He placed a small piece of gauze in the center of a small piece of surgical tape, and what we know today as the Band Aid bandage was born!
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5658886 | Acridinone derivative, compositions containing same and a method for using same to treat Chlamydia trachomatis The claims cover a bioactive compound N-methyl-N--D-glucopyranosil-ammonium-2-acridone-9-on-10-yl-acetate designated CYCLOFERONE which was obtained by chemical synthesis and is a heterocyclic compound. Specifically CYCLOFERONE is an acridanone ... | 08/19/1997 |
| 5658946 | Methods for the treatment of herpes virus infections Disclosed are methods for treatment of herpes virus infections in a human or lower animal subject comprising administering to the subject stannous salt and one or more pharmaceutically acceptable carriers suitable for topical administration. The stannous ... | 08/19/1997 |
| 5656628 | Use of L-acetylcarnitine for the treatment of AIDS This invention relates to the use of L-acylcarnitine for the preparation of a drug and a technique for relieving the disease symptoms appearing in AIDS by administering an L-acylcarnitine. The invention furthermore relates to a drug for this purpose, char... | 08/12/1997 |
| 5631245 | Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions Adverse inflammatory reactions can be treated by administrating to an organism a composition having diglucosylamine as the active ingredient. The preferred compound is di-Beta-D-glucopyranosylamine. A simple method for making diglucosylamine in high purit... | 05/20/1997 |
| 5599551 | Genital lubricants containing zinc as an anti-viral agent This invention relates to an article of manufacture comprising an aqueous gel containing a selected zinc salt contained within a deformable plastic-walled tubular container, for convenient and consistent use as a topical genital lubricant during acts of s... | 02/04/1997 |
| 5580571 | Nucleoside analogues Compositions for topical use in herpes virus infections comprising anti-herpes nucleoside analogue phosphate esters, such as acyclovir monophosphate and acyclovir diphosphate, which show increased activity against native strains of herpes virus as well as... | 12/03/1996 |
| 5565438 | L-nucleosides for the treatment of epstein-bar virus A method for the treatment of a human infected with EBV that includes administering an EBV-treatment amount of an L-nucleoside of the formula: ##STR1## wherein R is 5-methyluracil, and R' is hydrogen, acyl, alkyl or a monophosphate, diphosphate or tr... | 10/15/1996 |
| 5545673 | Method for reducing risk of infection by sexually transmitted viruses A method is disclosed for reducing the risk of infection by sexually transmitted viruses. This method involves spreading a lubricant fluid containing a selected zinc salt across the surfaces of the penis or vagina, before intercourse, in a manner that cau... | 08/13/1996 |
| 5521163 | Antiviral pyrimidine nucleosides and methods for using same 1'-Deoxy-5-ethyl-4'-thio-ଲ-uridine as a compound including its physiologically functional derivatives, pharmaceutical compositions containing it and methods of treating herpes virus infections are described.... | 05/28/1996 |
| 5503853 | Prophylactic and therapeutic applications of peroxidases Prophylactic and therapeutic applications of peroxidases for the manufacture of medicaments for the treatment and prevention and treatment of enveloped virus infections and, in particular, of herpes simplex and immunodeficiency virus infections. The medic... | 04/02/1996 |
| 5466680 | Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface The present invention relates to a method for enhancing white blood cell functioning and metabolism on a mucosal surface of a mammal. The present invention also relates to a method for treating or preventing a condition in a mammal caused by the presence ... | 11/14/1995 |
| 5458889 | Methods and compositions for inhibiting or destroying viruses or retroviruses This invention relates to a method and composition for inhibiting or destroying viruses or retroviruses in a mammalian host. The method comprises contacting the viruses or retroviruses with a composition. The composition comprises an active ingredient cap... | 10/17/1995 |
| 5441727 | Diketone deodorant composition and method of deodorization The present invention provides deodorant compositions for controlling malodor from perspiration comprising a safe an effective amount of a 1,3-diketone compound having the general formula: ##STR1## wherein each W is independently selected from the gr... | 08/15/1995 |
| 5439685 | Pharmaceutical composition for the prevention of sexually transmitted diseases A pharmaceutical composition for the prevention of sexually transmitted diseases, intended to be contacted with a mucosa. The composition contains, on the one hand, at least one constituent active against the viruses and bacteria responsible for the said ... | 08/08/1995 |
| 5422115 | Methods of treatment and devices employing lithium salts Methods of treatment of the human or animal body are provided to combat conditions responsive to lithium and/or C18-22 polyunsaturated fatty acid therapy, including conditions associated with essential lithium deficiency, and also transfer of l... | 06/06/1995 |
| 5384134 | Anti-inflammatory formulations for inflammatory diseases There is disclosed a method for treating dermatologic diseases caused by microbial overgrowth or inflammation, such as psoriasis, fungal infections, eczema, dandruff, acne, genital herpes lesions, and leg ulcers. There is further disclosed an antiviral lu... | 01/24/1995 |
| 5380529 | Pharmaceutical, vaginal applicable preparation and a process for its preparation The pharmaceutical, vaginal applicable preparation is characterized in that it contains, homogeneously sub-divided, at least one in water soluble poly-vinyl alcohol, at least one component A, selected from the group consisting of wetting agents, non-ionic... | 01/10/1995 |
| 5371107 | Use of ascorbic acid in the genital area and corresponding medicinal preparations A method of treating conditions of amine vaginitis, purulent vaginitis and dysplasia of the mouth of the uterus resulting from papilloma virus infection in the genital region of female animals by topically applying ascorbic acid to the affected region. Th... | 12/06/1994 |
| 5322689 | Topical aromatic releasing compositions The present invention relates to topical aromatic releasing compositions substantially free from petrolatum and containing one or more volatile aromatic compounds selected from the group consisting of menthol, camphor and eucalyptus oil and mixtures there... | 06/21/1994 |
| 5314689 | Acyl-carnitine for the treatment and prevention of viral infections Acyl-Carnitine in pharmaceutical formulations provides therapeutic and preventive antiviral action against HSV, CMV, VZV, HIV and others.... | 05/24/1994 |
| 5236905 | In vitro method of inhibition of HIV using transforming growth factor-.beta . The use of TGF-ଲ to inhibit HIV infection and/or replication is described. Both mature and precursor forms of TGF-ଲ are efficacious in inhibiting production of HIV. The TGF-ଲ used to inhibit HIV may be obtained from natural sources or ma... | 08/17/1993 |
| 5232695 | Method of ameliorating herpes simplex virus infections using purified nerve growth factor Methods of treatment are described for use of purified nerve growth factor to ameliorate viral infections in an animal caused by Herpes Simplex Virus Types 1 and 2. Compositions are described for use in the treatment comprising purified nerve growth facto... | 08/03/1993 |
| 5232700 | Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient A piracetam-containing preparation is applied to prevent and/or treat recurrent herpetic lesions. When used prophylactically, the piracetam-containing preparation is applied during the prodromal phase of a herpes recurrence at the site of previous eruptio... | 08/03/1993 |
| 5208031 | Sexual lubricants containing zinc as an anti-viral agent This invention relates to the use of zinc salts as anti-viral agents in sexual lubricants. A zinc salt which releases divalent zinc ions in an aqueous carrier fluid is provided in a sexual lubricant formulation which is spread on the genitals before sexua... | 05/04/1993 |
| 5080902 | Article and a prophylactic composition containing a microbicide A prophylactic agent for controlling venereal diseases. As an active microbicidal component, the agent has an ammonium compound having hydrolyzable ester group.... | 01/14/1992 |
| 4956184 | Topical treatment of genital herpes lesions There is disclosed a method for treating dermatologic diseases caused by microbial overgrowth or inflammation, such as psoriasis, fungal infections, eczema, dandruff, acne, genital herpes lesions, and leg ulcers. There is further disclosed an antiviral lu... | 09/11/1990 |
| 4801444 | Medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis A medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis comprises an efficient quantity of an active principle which is essentially a synergistic mixture of para-nitro-alpha-chlorocinnamic aldehyde... | 01/31/1989 |
| 4732763 | Active/passive immunization of the internal female reproductive organs Antibody or antigen containing microparticles for the active or passive immunization of the internal female reproductive organs, comprising: microparticles of an antigen or antibody incorporated in a matrix material which is biocompatible and biologically... | 03/22/1988 |
| 4657761 | Polyvalent non-specific immuno-stimulating vaccine and method A non-specific therapeutic polyvalent vaccine for subcutaneous injection containing a minimum combination of a PPD (tuberculin vaccine), a rabies vaccine, and snake venom vaccine and preferably including at least a DTP vaccine in addition and optimally a ... | 04/14/1987 |
| 4585651 | Active/passive immunization of the internal female reproductive organs Antibody or antigen containing microparticles for the active or passive immunization of the internal female reproductive organs, comprising: microparticles of an antigen or antibody incorporated in a matrix material which is biocompatible and biologically... | 04/29/1986 |
| 4548819 | Derivatives of 9-(2-hydroxyethoxymethyl) guanine Compounds of the general formula ##STR1## (wherein X represents an oxygen or sulphur atom, R1 represents a hydroxy or amino group, R2 represents a hydrogen atom or a group of formula --CH2 OR3a a... | 10/22/1985 |
| 4483851 | Treatment for contagious equine metritis A composition is provided for the treatment of contagious equine metritis, a contagious veneral disease of horses, which composition comprises an aqueous solution of dextrose, a buffering mixture to provide a pH of about 3.0 to 4.5, and a carrier, the com... | 11/20/1984 |
| 4424220 | Treatment of giardiasis and trichomoniasis Fluorouracil and emimycin are useful in the treatment of giardiasis and trichomoniasis.... | 01/03/1984 |
| 4405610 | Drug for curing inflammatory and/or degenerative and/or atrophic mucous-membrane diseases The invention relates to a pharmacuetical agent for curing inflammatory and/or degenerative and/or atrophic mucous-membrane diseases, more particularly for local application, which are characterized by the proportion of the nucleoside inoside (=hypoxanthi... | 09/20/1983 |
| 4102998 | Process for the prevention of venereal disease An intrauterine contraceptive device comprising an elongated shank having divergent convoluted portions at its distal end, said convoluted portions being generally sinusoidal in nature, said device having incorporated in said shank a permanent magnet and ... | 07/25/1978 |
| 4060616 | Purine derivatives with repeating unit 9-[2-(2-Hydroxyethoxy)ethoxymethyl] and related derivatives of certain 2-amino-6-substituted purines have been discovered to have potent anti-viral activities. Novel compounds and their pharmaceutically acceptable salts, pharmaceutical formulations contai... | 11/29/1977 |
| 3991190 | Treatment of viral infections A composition of cysteamine and a compound represented by the formula ##SPC1## Where R is hydrogen, --CHO or ##EQU1## useful for the treatment of an animal infected with a virus.... | 11/09/1976 |